Search This Blog

Friday, August 21, 2026

Arbutus tender offer to repurchase up to US$230M of common at US$5.00–US$5.75

 

Arbutus Biopharma to launch modified Dutch auction tender offer to repurchase up to US$230M of common shares at US$5.00–US$5.75

  • Tender offer will be funded with the company's existing cash on hand, according to Arbutus Biopharma.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)